Details
Stereochemistry | ACHIRAL |
Molecular Formula | 4Cl.2K.Pt |
Molecular Weight | 415.093 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[Pt++]
InChI
InChIKey=RVRDLMCWUILSAH-UHFFFAOYSA-J
InChI=1S/4ClH.2K.Pt/h4*1H;;;/q;;;;2*+1;+2/p-4
Molecular Formula | K |
Molecular Weight | 39.0983 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Pt |
Molecular Weight | 195.084 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Potassium tetrachloroplatinate is used in the preparation of platinum (Pt) nanoparticles. Ligands like ammonia or triphenyl phosphine can able to replace the chloride ligands to afford various derivatives. The replacement by ammonia results in the preparation of cisplatin, which is used in the cancer treatment. Further, it is used as catalyst in the hydroarylation reaction. Cisplatin and potassium tetrachloroplatinate are shown to bind to DNA that encapsulates SWNTs in aqueous solution. The bound platinum salt can then be reduced to decorate the DNA-encapsulated SWNTs with platinum nanoparticles. The unique combination of catalytic activity of nanoscale platinum, biological functionality of DNA, and optoelectronic properties of SWNTs suggests a myriad of applications including fuel cells, catalysts, biosensors, and electrochemical devices.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1909490 |
|||
Target ID: CHEMBL3070 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19702435 |
|||
Target ID: CHEMBL3730 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3569272 |
|||
Target ID: CHEMBL5917 Sources: https://www.ncbi.nlm.nih.gov/pubmed/166679 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Inhibition of HIV-1 proteinase by metal ions. | 1992 Jun |
|
Specific inhibition of rRNA transcription and dynamic relocation of fibrillarin induced by mercury. | 2000 Aug 25 |
|
Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. | 2002 Dec |
|
Detection of immunotoxicity using T-cell based cytokine reporter cell lines ("Cell Chip"). | 2005 Jan 15 |
|
Interleukin-1beta and surface marker expression changes induced by tetrachloroplatinate in human monocyte-derived dendritic cells. | 2010 Mar |
|
Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes. | 2010 Nov 10 |
Sample Use Guides
In Vivo Use Guide
Sources: http://datasheets.scbt.com/sc-264138.pdf
Oral (Human) LD: 400 mg/kg
Oral (Human) TDLo: 8.571 mg/kg
Dermal (Human) TDLo: 40 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19702435
Potassium tetrachloroplatinate (150 uM) induced up-regulation of IL-1beta mRNA, CD54, CD86, but not HLA-DR expression on in vitro cultured human monocyte-derived dendritic cells (MoDCs).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:48:10 GMT 2023
by
admin
on
Fri Dec 15 19:48:10 GMT 2023
|
Record UNII |
B74O00UCWC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
175496
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY | |||
|
233-050-9
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY | |||
|
61440
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY | |||
|
m9071
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID10904020
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY | |||
|
B74O00UCWC
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY | |||
|
POTASSIUM TETRACHLOROPLATINATE
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY | |||
|
10025-99-7
Created by
admin on Fri Dec 15 19:48:10 GMT 2023 , Edited by admin on Fri Dec 15 19:48:10 GMT 2023
|
PRIMARY |